Anti-SARS-CoV-2 monoclonal antibodies for the treatment of mild-to-moderate COVID-19 in multiple sclerosis: A retrospective cohort study.
Mult Scler Relat Disord
; 79: 104943, 2023 Nov.
Article
in En
| MEDLINE
| ID: mdl-37716211
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19
/
Multiple Sclerosis
Type of study:
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Mult Scler Relat Disord
Year:
2023
Document type:
Article
Affiliation country:
United States
Country of publication:
Netherlands